ALDH1A3 and central nervous system cancer: Indeed, ALDH1A3 was shown to support self-renewal and clonogenic potential of cancer stem cells (Duan et al., 2016), including glioma stem cells (Mao et al., 2013), which can differentiate into neurons and glial cells like NPCs (Lathia et al., 2015).